Hamilton Thorne Ltd. (CVE:HTL – Get Free Report)’s stock price traded up 4.3% on Monday . The company traded as high as C$1.45 and last traded at C$1.45. 25,700 shares changed hands during trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Stock Performance
The stock’s 50-day moving average price is C$1.45 and its 200-day moving average price is C$1.45. The company has a current ratio of 2.04, a quick ratio of 2.25 and a debt-to-equity ratio of 43.24. The company has a market capitalization of C$149.69 million, a P/E ratio of 58.94 and a beta of 0.54.
Hamilton Thorne Company Profile
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Featured Stories
- Five stocks we like better than Hamilton Thorne
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
